Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts by Klemmt, Petra A. B. et al.
RESEARCH Open Access
Murine amniotic fluid stem cells contribute
mesenchymal but not epithelial components to
reconstituted mammary ducts
Petra AB Klemmt, Vida Vafaizadeh, Bernd Groner
*
Abstract
Introduction: Amniotic fluid harbors cells indicative of all three germ layers, and pluripotent fetal amniotic fluid
stem cells (AFSs) are considered potentially valuable for applications in cellular therapy and tissue engineering. We
investigated whether it is possible to direct the cell fate of AFSs in vivo by transplantation experiments into a
particular microenvironment, the mammary fat pad. This microenvironment provides the prerequisites to study
stem cell function and the communication between mesenchymal and epithelial cells. On clearance of the
endogenous epithelium, the ductal tree can be reconstituted by the transfer of exogenously provided mammary
stem cells. Analogously, exogenously provided stem cells from other tissues can be investigated for their potential
to contribute to mammary gland regeneration.
Methods: We derived pluripotent murine AFSs, measured the expression of stem cell markers, and confirmed their
in vitro differentiation potential. AFSs were transplanted into cleared and non cleared fat pads of
immunocompromised mice to evaluate their ability to assume particular cell fates under the instructive conditions
of the fat-pad microenvironment and the hormonal stimulation during pregnancy.
Results: Transplantation of AFSs into cleared fat pads alone or in the presence of exogenous mammary epithelial
cells caused their differentiation into stroma and adipocytes and replaced endogenous mesenchymal components
surrounding the ducts in co-transplantation experiments. Similarly, transplantation of AFSs into fat pads that had
not been previously cleared led to AFS-derived stromal cells surrounding the elongating endogenous ducts. AFSs
expressed the marker protein a-SMA, but did not integrate into the myoepithelial cell layer of the ducts in virgin
mice. With pregnancy, a small number of AFS-derived cells were present in acinar structures.
Conclusions: Our data demonstrate that the microenvironmental cues of the mammary fat pad cause AFSs to
participate in mammary gland regeneration by providing mesenchymal components to emerging glandular
structures, but do not incorporate or differentiate into ductal epithelial cells.
Introduction
The developing fetus is surrounded by a protective layer
of liquid, the amniotic fluid. This fluid provides mechan-
ical protection as well as nutrients required for fetal
growth and well-being and contains cells derived from
embryonic and extraembryonic tissues [1]. The initial
cultures of amniotic fluid cells comprise a heteroge-
neous mixture of cell types [2,3], and differentiated cells,
progenitor cells, and embryonic-like stem cells have
been detected [4]. These cells exhibit differences in their
adherence to culture plates. During prolonged culture,
these cells acquire a more-homogeneous appearance
and resemble fibroblast-like cells. The different origins
of these cells can be determined with immunohisto-
chemistry. The majority of amniotic fluid cells appear
fibroblastoid, are rapidly proliferating, and co-express
keratins and vimentin [5-7]. Cells derived from back-
flush cultures of amniocentesis specimens, obtained for
prenatal genetic-screening procedures, were used for
in vitro differentiation assays. They initially demon-
strated multipotency, and the expression of embryonic * Correspondence: groner@em.uni-frankfurt.de
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tent subpopulation [4,8,9].
In the meantime, it has been shown that amniotic fluid-
derived stem cells (AFSs) are able to differentiate into neu-
rogenic lineages and thus contribute to the ectodermal
layer; into osteoblasts, fibroblasts, adipocytes, chondro-
cytes, and endothelial cells, as part of the mesodermal line-
age, and into hepatocytic cells as part of the endodermal
lineage. These cell-differentiation programs were triggered
by culturing the AFSs in a wide spectrum of different
media [10]; for example, basic fibroblast growth factor
(bFGF), epidermal growth factor (EGF), and N-ethylmalei-
mide-sensitive factor (NSF-1) were required to induce the
neuronal differentiation [11], and indomethacin, dexa-
methasone, methyl-3-isobutylxanthine, and insulin were
added to the medium to achieve adipogenesis [8]. The
multipotent nature of AFSs and the possibilities of differ-
entiating them into diverse cell types have made them
interesting candidates for therapeutic applications.
We investigated the plasticity of murine AFSs and their
potential to adapt to a particular microenvironment. For
this purpose, we performed transplantation experiments
of AFSs into the mammary fat pads of mice.
The mammary gland is a highly dynamic organ; its
development is mainly postnatal, and its tissue composi-
tion changes in a characteristic fashion during puberty,
pregnancy, lactation, and involution [12]. The branching
ducts are of ectodermal origin and consist of a single
layer of luminal epithelial cells surrounded by a contrac-
tile layer of myoepithelial cells, causing milk ejection
with oxytocin induction. The myoepithelial cells are in
direct contact with an extracellular basement membrane
and contribute its components. They are instrumental
for the establishment of ductal polarity and lumen forma-
tion [13]. The mammary ducts are embedded in an adi-
pose stroma of mesodermal origin, which consists mainly
of adipocytes, but also comprises fibroblasts, endothelial
cells, and immune cells involved in the regulation of
mammogenesis [14]. The ducts infiltrate the adipose
stroma during puberty, and the alveolar structures that
grow out during pregnancy are interspersed with islands
of adipocytes. During lactation, the adipocytes lose most
of their fat content, but persist as long projections in the
interstitial space. A layer of fibrous connective tissue is
present around the ducts and the secretory alveoli [15].
The cyclical nature of cell proliferation, differentiation,
and apoptosis and the regenerative capacity of the
epithelium during successive cycles of pregnancy, lacta-
tion, and involution require the presence and activity of
stem cells [16,17]. A unique feature of mammary stem
cells is their ability to reconstitute the ductal component
of the mammary gland with transplantation into cleared
fat pads [18]. This is a distinct property of the mam-
mary system and is comparable to the reconstitution of
the hematopoietic system by stem cell transplantation
[19]. In these circumstances, stem cells are functionally
selected by their reconstitution ability in vivo.
Transplantation of stem cells from adult male semini-
ferous tubules and of neural stem cells from embryonic
or adult brain into fat pads was shown to adopt func-
tional mammary epithelial cell traits, but only in con-
junction with normal, stem cell-depleted mammary
epithelial cells after pregnancy. These results indicate
that tissue-specific signals from the mammary stroma
cooperate with signals originating from differentiated
mammary epithelial cells and that these combined influ-
ences are capable of directing the fate of stem cells from
heterologous organs [20,21].
The ready availability of AFSs and the expectations
that these cells might become a convenient source for
therapeutic applications caused us to investigate their
adaptability to a particular organ microenvironment and
their potential to contribute to mammary gland struc-
tures. Cultured AFSs by themselves or mixed with pri-
mary mammary epithelial cells were introduced into
cleared and noncleared fat pads of mice to gauge their
plasticity toward mammary epithelial differentiation.
Our results indicate that the signals operating in this
microenvironment trigger an exclusive mesenchymal dif-
ferentiation program of transplanted AFSs, irrespective
of the presence of mammary epithelial cells in virgin
mice. The AFSs proliferate and persist during mammary
gland development, interact closely with endogenous or
transplanted mammary epithelial cells, and provide stro-
mal components and adipocytes surrounding the ductal
structures. Under the hormonal influence of pregnancy,
a very small number of AFS-derived cells appear present
in acinar structures between the basement membrane
and the myoepithelium.
Materials and methods
Mice
C57BL/6-Tg (ACTB-EGFP) and B6;129S-GT(ROSA)
26Sor/J (Rosa26) from Jackson Laboratories (Charles
River, Sulzfeld, Germany) were used as donor mice for
amniotic fluid or mammary epithelial cell isolation.
Female RAG2 KO mice (BALB/cA-RAG2KO, IL-2RgKO)
from Central Institute for Experimental Animals (CIEA,
Kawasaki, Japan) were used as hosts for the transplanta-
tion studies. All mice were maintained in a pathogen-free
facility, and the experimental procedures were approved
by the Animal Welfare office of the Regierungspräsidium
Darmstadt.
Isolation and culture of AFSs from murine amniotic fluid
Amniotic fluid was collected from pregnant donor mice at
embryonic day 13.5 by rupturing the yolk sac with a 27-
gauge needle, and recovered cells were cultured in 35-mm
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Germany) by using a two-stage culture method [9]. In
brief, after an initial expansion of 5 days, the nonadherent
amniotic fluid cells in the supernatant were collected,
centrifuged for 5 min at 300 g, and replated in AmnioMax
complete for a further 5 days, by which they acquired an
adherent phenotype. Established AFS lines were passaged
at a dilution of 1:4 to 1:8 in DMEM supplemented with
10% fetal calf serum (FCS), 50 units/ml and 50 μ/ml peni-
cillin-streptomycin, and 2 mM L-glutamine (DMEM com-
plete; all from Invitrogen, Darmstadt, Germany).
FACS analysis
For flow-cytometric analysis, 5 × 10
5 cells were fixed for
5 min in 3% para-formaldehyde (PFA, Sigma-Aldrich,
Munich, Germany), washed with PBS (PAA Laboratories
GmbH, Cölbe, Germany), and incubated with 1 μlf l u o r -
escence-conjugated antibodies in 200 μl PBS against
CD24, CD29, CD44, CD117, Sca-1, CD49f, CD90.2 (all
BD Biosciences, Heidelberg, Germany), and CD31 and
CD45 (Biolegend, BIOZOL Diagnostica Vertrieb GmbH,
Eching, Germany) or their respective IgG controls for 20
m i ni nt h ed a r k .A f t e rt w ow a s h i n gs t e p sw i t hP B S ,c e l l s
were analyzed by using a FACS Scan (Becton Dickinson,
Heidelberg, Germany) flow cytometer with CellQuest
software (Becton Dickinson, Heidelberg, Germany).
Immunocytochemistry
AFS cultures were fixed in 3% PFA, permeabilized (10 mM
HEPES, 200 mM sucrose, 3 mM MgCl2,5 0m M NaCl,
0.5% Triton X-100, 0.2% NaN3, all from Sigma-Aldrich,
Munich, Germany) and blocked in 3% BSA (Sigma-
Aldrich, Munich, Germany). Specific antigens were
detected by incubation with antibodies to a-keratin 18
(clone KS18.04; Progen Biotechnik GmbH, Heidelberg,
Germany, ready-to-use), a-keratin 14 (clone AF64;
Covance, HiSS Diagnostics GmbH, Germany, 1:200),
a-vimentin (ab45939; abCam, Cambridge, UK, 1:500),
a-CD44-CyChrome (clone IM7; BD Biosciences, Heidel-
b e r g ,G e r m a n y ,1 : 6 0 ) ,a n da-SMA (clone 1A4; Sigma-
Aldrich, Munich, Germany, 1:500) for 1 h at RT in 0.1%
BSA followed by incubation with 10 μ/ml of donkey
anti-mouse AlexaFluor546-conjugated IgG (Invitrogen,
Darmstadt, Germany) or donkey anti-rabbit Alexa-
Fluor488-conjugated IgG (Invitrogen, Darmstadt, Ger-
many) for 45 min at RT in the dark and mounted in
Mowiol containing 1.5 μg/ml DAPI. Staining was assessed
by using a Nikon Eclipse TE300 microscope and NIS
Elements AR imaging software (Nikon, Düsseldorf,
Germany).
Differentiation protocols
AFS were cultured to confluence in DMEM complete
before the addition of adipogenic supplements (1 μM
dexamethasone, 0.5 mM isobutylmethylxanthine, 5 μ/ml
Insulin, and 60 μM indomethacin, all from Sigma-
Aldrich, Munich, Germany), osteogenic supplements
(100 nM dexamethasone, 10 mM b-glycerolphosphate,
and 50 μM 2-phospho ascorbic acid, all from Sigma-
Aldrich, Munich, Germany) or epithelial supplements
(10 ng/ml keratinocyte growth factor, 10 ng/ml hepato-
cyte growth factor, 60 ng/ml insulin-like growth factor II
(all from BIOZOL Diagnostica Vertrieb GmbH, Eching,
Germany), and20 ng/ml epidermal growth factor
(BD Biosciences, Heidelberg, Germany),) in DMEM con-
taining 10% FCS and antibiotics for 14 days. The differ-
entiation medium was changed every 4 days. The
differentiation potential for adipogenesis was assessed
with the visualization of lipid vacuoles by using Oil Red
O staining (Sigma-Aldrich, Munich, Germany); the
deposition of mineralized calcium accumulation during
osteogenesis was detected by Alizarin Red S staining
(Sigma-Aldrich, Munich, Germany), and the epithelial
character was confirmed with Ayoub Shklar staining [22].
Measurement of mRNA expression with RT-PCR
Total RNA was extracted from cultured, noninduced or
differentiated AFSs by using NucleoSpin RNA II
(Macherey & Nagel, Düren, Germany) according to the
manufacturer’s instructions. RNA was then reverse tran-
scribed by using Superscript II reverse transcriptase
(Invitrogen, Darmstadt, Germany), and RT-PCR was
performed by using standard protocols. The amplified
DNA fragments were subjected to 1.5% agarose gel
electrophoresis.
Isolation and culture of mammary epithelial cells
Mammary glands were isolated from 10-week-old virgin
female C57BL/6-Tg (ACTB-EGFP) or B6;129S-GT(ROSA)
26Sor/J, mice as previously described [17]. The organoids
were purified with pulse centrifugation and plated on a
thin gel of collagen type I (BD Biosciences, Heidelberg,
Germany) in Ham’s F-12 (PAA Laboratories GmbH,
Cölbe, Germany) supplemented with 5% FCS, 5 μ/ml insu-
lin (Sigma-Aldrich, Munich, Germany), 1 μ/ml hydrocorti-
sone (Sigma-Aldrich, Munich, Germany), 5 ng/ml EGF,
50 units/ml-50 μ/ml penicillin-streptomycin, and 50 μ/ml
gentamicin (Invitrogen, Darmstadt, Germany). Primary
cultures were passaged once, 3 to 4 days after plating
before transplantation.
Three-dimensional cell-culture system
The 3D culture of AFSs and MECs was performed as
described [23]. In brief, cells were trypsinized and resus-
pended in assay medium (DMEM/F12 containing 2%
FCS, 0.5 μ/ml hydrocortisone, 100 ng/ml choleratoxin
(Sigma-Aldrich, Munich, Germany), 10 μ/ml insulin) at
a concentration of 25,000 cells/ml. Eight-chamber glass
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Germany) were coated with 45 μl growth factor reduced
Matrigel (BD Biosciences, Heidelberg, Germany) per
well and left to gel at 37°C for 15 min. The cells were
mixed 1:1 with assay medium supplemented with 4%
Matrigel and 10 ng/ml EGF, and 400 μlo ft h i sm i x t u r e
was added to each well. Assay medium supplemented
with 2% Matrigel and 5 ng/ml EGF was replaced every
4 days. Acini formation was assessed after 5 days by
using a Nikon Eclipse TE300 microscope and NIS Ele-
ments AR imaging software (Nikon, Düsseldorf, Ger-
many) and after 10 days by using a Leica TCS SL
confocal microscope and Leica Confocal software ver-
sion 2.61 (Leica Microsystems, Wetzlar, Germany).
Immunostaining of 3D cultures was performed as
described [24] with antibodies to a-vimentin (ab45939,
abCam, Cambridge, UK; 1:500) and a-SMA (clone 1A4,
Sigma-Aldrich, Munich, Germany; 1:500).
Cell transplantation into mammary fat pads
The 3-week-old Rag 2
-/- r e c i p i e n tm i c ew e r ea n e s t h e -
tized, and the endogenous epithelium was removed
from both number 4 inguinal mammary glands. AFSs
alone or mixed with MECs were resuspended in 10 μl
cold Matrigel and injected into the remaining fat pad,
cleared of its epithelial component. The hosts were ana-
lyzed 8 weeks later. The GFP
+ outgrowths were visua-
lized by using a Leica MZ16F stereomicroscope and
LAS version 2.8 (Leica Microsystems, Wetzlar, Ger-
many), fixed in 4% formalin for 1 h at 4°C, and incu-
bated in X-gal staining solution (10 mM K3Fe(CN)6,
10 mM K4Fe(CN)6, 0.2% NP-40, 0.1% Triton X-100, and
1 mg/ml X-Gal, all from Sigma-Aldrich, Munich, Ger-
many) overnight at 37°C to visualize b-galactosidase-
positive outgrowth. Stained glands were rinsed in PBS,
photographed, postfixed in 4% formalin, and embedded
in paraffin.
Immunohistochemistry
Immunohistochemical analysis was performed on forma-
lin-fixed paraffin sections (5 μm), cleared in xylene, and
rehydrated through an alcohol series. Antigen retrieval
by using 10 mM sodium citrate buffer, pH 6, was per-
formed for all antibodies except a-SMA. IHC-HRP stain-
ing was performed by using the Envision detection
system Peroxidase/DAB (Dako, Hamburg, Germany) and
the M.O.M. kit (Vector Laboratories, BIOZOL Diagnos-
tica Vertrieb GmbH, Eching, Germany) according to the
manufacturer’s instructions. Slides were counterstained
with hematoxylin or Nuclear fast red, dehydrated, and
mounted with Assistent-Histokitt. Staining was assessed
by using a Leica DMLS microscope (Leica Microsystems,
Wetzlar, Germany) and LAS version 2.8. For IHC-IF
staining, the sections were blocked in 0.1 mg/ml goat
anti-mouse IgG (Jackson ImmunoResearch, Dianova,
Hamburg, Germany) and 10% FCS in PBS for 1 h. Pri-
mary antibodies were incubated in 1% FCS overnight at
4°C followed by incubation with 10 μ/ml goat anti-mouse
AlexaFluor488-conjugated IgG (Invitrogen, Darmstadt,
Germany), donkey anti-rabbit AlexaFluor647-conjugated
IgG (Invitrogen, Darmstadt, Germany), and donkey anti-
goat AlexaFluor594-conjugated IgG (Invitrogen, Darm-
stadt, Germany) for 45 min at RT in the dark and
mounted in Mowiol containing 1.5 μg/ml DAPI. Staining
was assessed by using a Leica TCS SP5 confocal micro-
scope and LAS AF imaging software (Leica Microsys-
tems, Wetzlar, Germany). Images were processed by
using Imaris (Bitplane, Zurich, Switzerland). The sources
of antibodies used in this study: a-GFP (2555; Cell
Signaling, New England Biolabs GmbH, Frankfurt,
Germany, 1:800); a-Keratin14 (clone AF64; Covance,
HiSS Diagnostics GmbH, Germany, 1:500); a-SMA
(clone 1A4; Sigma, Munich, Germany, 1:500), a-vimentin
(clone C20; Santa Cruz, Heidelberg, Germany, 1:500),
a-c/EBPa (clone 14AA; Santa Cruz, Heidelberg, Ger-
m a n y ,1 : 5 0 ) ,a n da-laminin b1 (clone C19; Santa Cruz,
Heidelberg, Germany, 1:50).
Results
Amniotic fluid-derived cells exhibit an epithelial
phenotype and are multipotent
We collected amniotic fluid from the yolk sac of mice at
day 13.5 of pregnancy and isolated amniotic fluid stem
cells (AFSs) by using a two-stage culture model [9].
Nonadherent amniotic fluid cells after 5 days of culture
were recovered from the medium and replated for a
further 5 days (Figure 1a). During this period, they
became adherent. In total, we established 20 AFS lines
from different donors. The rapidly adhering cells iso-
lated during the initial plating period of 5 days under-
went growth senescence within three passages.
Morphologically, undifferentiated AFSs obtained during
the second culture period appear spindle shaped and
resemble fibroblasts.
We characterized the freshly isolated and cultured AFSs
with respect to the expression of genes that are indicative
of stem-cell phenotypes and measured the mRNA levels of
Oct-4, SSEA-1, Nanog, ZFX, Tbx3,a n dBmi-1. These genes
have been found to maintain cells in a pluripotent, undif-
ferentiated state, and Nanog is a master regulator of pluri-
potency in embryonic stem cells. The expression of
Nanog, Zfx, and Tbx3 persists at least for 15 passages, and
Bmi-1 w a sd e t e c t e du pt op a s s a g e3( F i g u r e1 b ) .F l o w
cytometry was used to visualize the expression of stem
cell-associated surface markers. The cultured AFSs express
predominantly markers of mesenchymal stem cells (CD44,
Sca-1, CD29, CD49f,a n dCD90) but lack marker expres-
sion of the hematopoietic compartment (CD31 and CD45)
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express CD117 to a similar degree as that reported for
human AFS lines [8]. Additionally, they express CD24,a
pan-epithelial marker in the mouse mammary gland [25].
The derived AFSs are epithelial in nature, as shown by
their expression of the luminal epithelial marker keratin
18 (K18) and the myoepithelial marker keratin 14 (K14).
At the same time, they express mesenchymal cells mar-
kers, (for example, vimentin and a-smooth muscle actin
(a-SMA) and the mesenchymal stem-cell marker CD44
(Figure 1d)).
The hallmark of adult stem cells is their ability to pro-
duce progeny of different lineages. We confirmed the
multipotency of the cultured murine AFS lines by their
differentiation capacity into various cell types in vitro,
a f t e r1 4d a y so fe x p o s u r et os pecific induction condi-
tions (Figure 1e). Differentiation of AFSs in adipogenic
medium [9] resulted in the formation of lipid vacuoles
Figure 1 Isolation, characterization, and differentiation potential of fetal stem cells derived from murine amniotic fluid. (a) Amniotic
fluid stem cells (AFSs) were isolated at E13.5 and obtained by using a two-step culture model [9] from C57/B6-TG (ACTB-EGFP) and Rosa26 mice.
(b) The freshly isolated and cultured AFSs exhibit pluripotency markers and exhibit no spontaneous differentiation in culture. (c) Histogram
analysis of cell-surface markers showed that AFSs express embryonic and mesenchymal stem cell markers but lack the expression of
hematopoietic cell markers. Grey line, isotype control. (d) Cultured AFSs exhibit an epithelial phenotype, as demonstrated by the co-expression
of keratins and vimentin. (e) Differentiation of AFSs into mesodermal cell types after specific stimulation for 14 days is marked by the
appearance of lipid granules (adipogenic) or mineralized matrix (osteogenic). The epithelial-stimulation protocol further potentiates the epithelial
nature of AFSs (epithelial). Insets show higher magnification of the treated cells. Scale bars, 50 μm.
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medium [9] caused the formation of functional osteo-
blasts characterized by the deposition of mineralized cal-
cium, as shown by Alizarin Red S staining. The
differentiation of AFSs in epithelial medium [26]
resulted in the enhancement of the epithelial keratin
expression, as shown by Ayoub Shklar staining, a modi-
fied Mallory connective tissue stain for keratins [22].
AFSs closely associate with mammary epithelial cells in
the formation of acini in 3D culture
The interaction of AFSs with primary mammary epithe-
lial cells (MECs) was tested in co-culture experiments.
A F S sd e r i v e df r o mC 5 7 B L / 6 - T g( A C T B - E G F P )d o n o r s
were either mixed with single-cell suspensions of MECs
isolated from Rosa26 mice before plating or added to
adherent MECs organoid cultures. Interestingly, MECs
formed islands after plating surrounded by GFP
+ AFS or
GFP
+ AFS were found in close association with the
organoids (data not shown). We extended these observa-
tions and performed three-dimensional culture (3D)
experiments in the Matrigel microenvironment. MECs
display distinct morphogenesis in 3D cultures; they
resemble features of the mammary gland architecture in
vivo [27]. When grown in the presence of basement
membrane components, MECs form hollow spherical,
acini-like structures with apicobasal polarization formed
by a single layer of polarized, growth-arrested cells [23].
AFS lines derived from Rosa26 donors grown under the
same conditions in the 3D Matrigel culture system
begin to form spherical structures within 5 days of cul-
ture, which extend to form tubular networks after
10 days (Figure 2a). This is comparable to the cordlike
structures obtained from human AFSs, pre-differentiated
toward the endothelial lineage [28]. Immunostaining of
the tubular structures showed the expression of the
mesenchymal markers vimentin and a-SMA (Figure 2b).
Closer investigation of the spherical structures revealed
the formation of a lumen after 10 days (Figure 2b,
inset).
We investigated whether AFSs can associate or coop-
erate with MECs and integrate into acinar structures
formed by MECs. Equal numbers of AFSs, derived from
Rosa26 donors, and MECs, derived from GFP transgenic
donors, C57BL/6-Tg (ACTB-EGFP), were cultured
under conditions that allow 3D differentiation. The for-
mation of acini was monitored 10 days after plating
(Figure 2c). We observed the emergence of branching
tubular structures formed by AFSs surrounding small
clusters of GFP
+ MECs (Figure 2c, upper panel) or
spheres formed by GFP
+ MECs with a hollow central
lumen surrounded by a layer of cells contributed by AFS
(Figure 2c, middle panel). The AFSs branched off the
acini and surrounded additional GFP
+ MECs (Figure 2c,
lower panel). Immunostaining experiments of the
obtained structures with a-SMA suggest that AFSs clo-
sely associate with MECs and contribute a-SMA
+
mesenchymal cells to emerging acini (Figure 2d) but do
not integrate into the MEC cell layer.
The microenvironment of the mammary fat pad triggers
AFS differentiation into mesenchymal cells
Mammary epithelial outgrowths can be observed in
cleared mammary fat pads transplanted with ductal frag-
ments or dispersed mammary cells. This procedure can
be used to identify mammary stem cells and to study
their properties. We used the fat-pad microenvironment
to investigate the regenerative potential of AFS lines
derived from GFP-transgenic mice, C57BL/6-Tg (ACTB-
EGFP). We compared amniotic fluid cells (AFs) that
became adherent within the initial culture period of 5
days and AFS that became adherent after only 5 days of
culture. AF cells and AFSs (2 × 10
5 each) were inocu-
lated into epithelium-divested inguinal mammary fat
pads of 3-week-old recipient Rag 2
-/- female mice, and
outgrowths were analyzed 8 weeks later with fluores-
c e n c em i c r o s c o p yo fw h o l em o u n t s .O n l yA F S st h a t
became adherent after day 5 of the isolation procedure
were able to implant and grow in cleared mammary fat
pads (Figure 3a, top panel). The GFP
+ outgrowths
derived from four independent transplantation experi-
ments with different GFP
+ AFS lines yielded mainly
connective tissue and contained a mixture of stromal
cells and adipocytes (Figure 3a, lower panel). Differentia-
tion into mammary epithelium was not detected. The
AFS differentiation capacity was not influenced by preg-
nancy hormones or tissue remodeling during involution.
This observation was confirmed with immunohisto-
chemistry on sections derived from the outgrowths
with antibodies specific for GFP, K14,a n da-SMA
(Figure 3b). K14 and a-SMA expression colocalized with
t h ee x p r e s s i o no fG F P .T h eG F P
+ cells originated from
t h et r a n s p l a n t e dA F S sa n dp r o v i d ec o n n e c t i v et i s s u e
components composed of stromal cells and adipocytes.
Immunohistochemical analysis showed that the cells ori-
ginating from the amniotic fluid stem cells (GFP
+)
expressed stromal cell markers (a-SMA and vimentin)
and adipocyte marker (C/EBPa) (Figure 3c).
We also examined the possibility that MECs might be
required for the participation of AFSs in ductal reconsti-
tution, analogous to the observations made with the
transplantation of neural stem cells [21]. It is conceiva-
ble that the co-transplantation of mammary epithelial
cells can alter the signals acting on AFSs. Equal num-
bers of MECs and AFS were combined (10
5 each) and
immediately inoculated into cleared fat pads of 3-week-
old Rag 2
-/- recipients. Both combinations (AFSs derived
from Rosa26 donors combined with GFP
+ MECs and
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combined with LacZ
+ MECs) were analyzed in virgin,
pregnant, and postlactation mice (Figure 4). Eight weeks
after transplantation, mice were either mated or ana-
lyzed as virgin mice. Whole mounts of the resulting
glands were subjected to fluorescence microscopy before
staining with X-Gal. The AFS progeny contributed ring-
like structures around the growing ducts (Figure 4a),
reminiscent of the results obtained in the 3D-culture
experiments in virgin mice. Histologic analysis revealed
that AFS-derived cells contributed stromal components
surrounding the mammary epithelial ducts in virgin
mice, but did not incorporate into the epithelial cell
layers (Figure 4b). The differentiation stimulus during
pregnancy did not alter the cell fate of the majority of
transplanted AFSs (Figure 4c). They contributed GFP
+
stromal components tightly associated with emerging
alveoli (Figure 4c, upper panel). Histologic analysis by
Figure 2 Amniotic fluid stem cells (AFSs) form spheres and tubular structures in 3D cultures. AFSs alone or equal numbers of AFSs and
MECs derived from GFP transgenic C57/B6-TG (ACTB-EGFP) mice were subjected to 3D differentiation and monitored for up to 10 days after
plating. (a) AFS-derived progeny form spherical structures 5 days after plating and extend to a branched tubular network in 3D Matrigel culture.
(b) These structures are positive for a-SMA and vimentin. Inset shows a section through a spherical structure. (c) We observed the emergence of
tubular structures formed by AFSs surrounding GFP
+ MECs (upper panel) or spheroids formed from GFP
+ MECs with a hollow central lumen
surrounded by a layer of cells contributed by AFSs (middle panel) and side branches surrounding GFP
+ MECs (lower panel). (d) AFSs closely
associated with GFP
+ MECs express a-SMA. Scale bars, 50 μm, and for inset, 30 μm.
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and laminin b1 revealed that a small number of GFP
+
AFSs can be detected associated with alveolar structures
(Figure 4c, lower panel). Thus AFS progeny do not
incorporate into ductal structures in virgin mice, but
can be found in acinar structures during pregnancy. The
engrafted AFSs persisted during involution (data not
shown).
AFSs inoculated into the mammary fat pads exhibit a
remarkable migratory potential
Previous studies indicated that transplanted AFSs can
migrate away from the injection site [29], and, if injected
intraperitoneally or intravenously, are able to diffuse sys-
temically and to integrate into various tissues [30,31].
We investigated whether AFSs inoculated into the
cleared mammary fat pads are able to migrate to other
organs. AFSs obtained from Rosa26 mice express the
LacZ gene, and their progeny can be monitored by
whole-mount staining of different organs. On injection
of these cells into the mammary fat pad, LacZ
+ progeny
of AFSs were detected in several organs. The cells
inoculated into the number 4 fat pad migrated to the
number 3 fat pad on the same side and also were found
in healing suture wounds (data not shown). The gastro-
intestinal tract contained the largest number of LacZ
+
Figure 3 Cell-fate tracing of transplanted amniotic fluid stem cells (AFSs) into cleared fat pads. (a) The 2 × 10
5 AF-derived cells (rapidly
adherent within 5 days) and AFSs (slowly adherent, after 5 days of culture) derived from various donors were transplanted into 3-week-old
recipient mice and analyzed 8 weeks later as whole mounts. Only the slowly adhering cells selected in the second culture step are able to
engraft and can be classified as AFSs. (b) Histologic analysis confirms that the GFP
+ AFSs survived and differentiated into adipocytes and
connective tissue. Scale bar for whole mounts and tissue sections is 50 μm, (Blue) X-Gal stain or hematoxylin, (Pink) Nuclear fast red, and (Brown)
DAB staining.
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Page 8 of 13cells, followed by the liver and the lung. The AFS-
derived cells integrated into the normal tissue architec-
ture (Figure 5).
The AFSs contribute stromal components to emerging
ducts
To investigate whether the AFSs can contribute meso-
dermal components to endogenous epithelium, we
injected 10
5 AFSs derived from a Rosa26 donor into
noncleared fat pads of 3-week-old Rag 2
-/- recipients in
close proximity to the nipple (Figure 6). Glands were
excised 2 weeks later, subjected to X-Gal staining, and
counterstained with carmine alum to visualize the ductal
epithelium. Whole-mount analysis demonstrates engraft-
ment and massive proliferation of the transplanted AFSs
(Figure 6a). The LacZ
+ c e l l sf i l lt h ef a tp a da r o u n dt h e
injection site and surround the endogenous, elongating
ducts, reminiscent of the co-transplantation experiments
with exogenously added MECs. Immunohistochemistry
of paraffin sections confirmed the presence of LacZ
+
cells in the stromal compartment of the extending endo-
genous ducts and around terminal end buds (TEBs), but
also revealed areas of adipocyte differentiation. The
LacZ
+ cells expressed the myoepithelial marker a-SMA,
but did not incorporate into the myoepithelial cell layer
(Figure 6b). Based on these observations, we conclude
Figure 4 Cell-fate tracing of amniotic fluid stem cells (AFSs) in co-transplantation with MECs into cleared fat pads. (a) AFSs were
transplanted in a 1:1 ratio with supporting MECs (10
5 each) and analyzed 8 weeks later. X-Gal-stained whole mounts from virgin mice show that
AFS-derived progeny surround the developing ductal structures. (b) Histologic analysis of whole mounts inoculated with AFSs and MECs
confirms that AFSs form a stromal cell layer around the ductal outgrowth but do not integrate into the myoepithelial or luminal cell layer in
virgin mice. (c) Histologic analysis of whole mounts at pregnancy day 18.5 inoculated with GFP
+ AFSs and MECs shows that the stromal cell
layer derived from GFP
+ AFSs exhibit no adverse effects on alveologenesis. Insets show higher magnification. Scale bar for whole mounts and
tissue sections is 50 μm. A few a-SMA
+ and GFP
+ AFS-derived cells can be detected within the alveolar unit, as shown by laminin b1 staining.
The circles indicate alveolar units. Scale bar is 10 mm. (Blue) X-Gal stain or hematoxylin, (Pink) Nuclear fast red, and (Brown) DAB staining.
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only trigger differentiation programs of AFS into
mesenchymal cells types, despite their original, partially
epithelial nature.
Discussion
Amniotic fluid-derived stem cells (AFSs) are a most ver-
satile cell population and are interesting for conceptual
and practical purposes. Conceptually, they can be used
to investigate the culture conditions and the molecular
signals required for stem cells to assume particular cell
fates. Practically, AFS, triggered by defined cues to dif-
ferentiate into certain cell types, can potentially be used
in transplantation studies for tissue repair or tissue
reconstitution. Despite their obvious potential value, a
routine procedure has yet to be established for the deri-
vation of AFSs, their growth in culture, and the mainte-
nance of their pluripotent nature.
Several protocols differ considerably from each other.
A single-step cultivation method has been used in
which AFSs are obtained after 7 days of cultivation
without medium changes [29,32-34]. A two-stage cul-
ture method favors the isolation of Oct-4-positive AFSs
[9] and the isolation of CD117-positive AFSs [8,30].
These methods use different growth media and isolation
methods and yield AFSs of distinct phenotypes. In our
experiments, we made use of the two-stage culture
method developed for the isolation and enrichment of
human AFSs obtained by amniocentesis for prenatal
diagnosis [9] and applied this method to the investiga-
tion of murine AFSs. During this procedure, AFSs
slowly adapt to adherent growth and can be classified
according to their morphologic appearance. The cells
maintain their ability to differentiate into adipogenic,
osteogenic, myogenic, endothelial, neurogenic, and hepa-
tic cells in vitro [8,9]. We consistently observed that the
amniotic fluid-derived stem cells became adherent
between days 5 and 7 after plating. These cells showed
unlimited proliferation and the maintenance of their dif-
ferentiation potential. Conversely, the amniotic fluid
cells that became adherent within the first 5 days after
plating underwent rapid growth senescence and did not
Figure 5 Amniotic fluid stem cells (AFS)-derived cells migrate to
other organs. The 10
5 AFSs derived from a Rosa26 donor were
injected into cleared fat pads of 3-week-old recipient mice and
analyzed 14 weeks later. X-Gal-stained whole mounts demonstrate
the presence of LacZ
+ cells in several organs. Tissue sections show
the localization of AFS-derived LacZ
+ cells between hepatocytes,
adjacent to airway epithelial cells, and in the mucosa of the
gastrointestinal tract. Scale bar for whole mounts is 500 μm, and for
sections, 50 μm, (Blue) X-Gal stain and (Pink) Nuclear fast red staining.
Figure 6 Amniotic fluid stem cells (AFS)-derived cells
contribute stromal components for extending ducts. The 10
5
AFSs derived from a Rosa26 donor were injected into noncleared
fat pads of 3-week-old recipient mice and analyzed 2 weeks later.
(a) Whole-mount analysis and tissue sections of X-Gal-stained whole
mounts demonstrate the presence of LacZ
+ cells in the stroma of
extending ducts. (b) AFS-derived LacZ
+ cells retain the expression of
a-SMA but did not integrate into the myoepithelial cell layer. Scale
bar for whole mount is 1,000 mm, and for tissue sections, 50 μm;
(*) injection site, (Blue) X-Gal stain, (Pink) Carmine alum or Nuclear
fast red staining and (Brown) DAB staining.
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Page 10 of 13engraft in cleared mammary fat pads, irrespective of the
presence of supporting mammary epithelial cells.
The majority of the murine AFSs used in this study
appeared fibroblastoid, proliferated rapidly, and co-
expressed keratins and vimentin, confirming their partial
epithelial nature. This is in contrast to bone marrow-
derived mesenchymal stem cells (BM-MSCs), which
need special medium supplements to differentiate
toward the epithelial lineage [26] and proliferate at a
lower rate than AFSs [35]. The multipotency of the
murine AFSs was confirmed by in vitro differentiation
assays. Adipogenic, osteogenic, and epithelial lineages
were observed.
In this study, we investigated whether the signals pro-
vided by the mammary microenvironment are sufficient
to redirect the cell fate of multipotent AFSs into mam-
mary epithelium. We also probed the influence of exo-
genously added mammary epithelial cells on the
differentiation potential of AFS in both in vitro and in
vivo assays. We investigated the in vitro morphogenesis
of AFSs in a 3D-on-top culture system, a test assay to
monitor mammary acinar architecture [23]. In this assay
system, we observed the formation of spherelike struc-
tures with a small lumen by AFSs followed by the emer-
gence of branched tubular structures that mimic the
sprouting of predifferentiated AFSs toward endothelium
[28] or endothelial precursor cells [36]. Interestingly, the
3D coculture of AFSs and MECs yielded similar results.
MECs were embedded in tubes formed by AFS or devel-
oped acinar structures surrounded by a layer of AFSs
extending away from the spherical structures. It appears
that the AFSs provide stromal components to the gland-
ular epithelium and form a scaffold around MECs.
We also analyzed the differentiation potential of AFSs
in vivo by transplantation experiments into cleared and
noncleared mammary fat pads. Previous studies using
cells from seminiferous tubules [20] or neural stem cells
[21] of male WAP-Cre/Rosa26 reporter mice showed
that the mammary microenvironment could alter the
intrinsic cell fate of exogenously provided stem cells
toward the mammary epithelial cell lineage after preg-
nancy. Mesenchymal stem cells from different sources
have the potential to differentiate into a variety of cells
under the influence of certain microenvironments.
Despite the partial epithelial nature of the cultured AFSs,
we consistently observed that the progeny of AFSs adopt
mesenchymal cell properties after transplantation into
the mammary microenvironment. This is in contrast to
the engraftment capacity of cells from seminiferous
tubules or neural stem cells, which did not persist in the
absence of supporting mammary epithelial cells [20,21].
The mammary fat pad is of mesodermal origin and pro-
vides factors that cause AFS differentiation toward
mesenchymal cell types. The morphogenetic capacity of
the ectoderm-derived mammary epithelium strongly
depends on the microenvironmental clues provided by
the fat pad. It is, therefore, interesting to note that AFSs
contribute stromal components to emerging ducts that
have no adverse effect on mammary epithelial repopula-
tion capacity. The engrafted AFSs continued to express
myoepithelial markers but did not integrate into the
luminal or myoepithelial layer of the emerging ducts in
virgin mice.
Myoepithelial cells play an important role in the mor-
phogenetic events during gland development and influ-
ence the proliferation, survival, and differentiation of
luminal cells and modulate stromal-epithelial interac-
tions [37]. Interestingly, we observed the presence of a
small number of AFS-derived cells in close proximity to
emerging alveoli during pregnancy.
At this point, we cannot distinguish between two possi-
ble interpretations. It is conceivable that AFSs are intrinsi-
cally limited in their differentiation potential, that they are
unable to assume the mammary epithelial cell fate, and
that the stroma-induced transdifferentiation potential of
fetal or adult tissue might be restricted to cell fates of the
same germ layer. For example, endoderm-derived pulmon-
ary and pancreatic epithelia failed to exhibit morphoge-
netic responses to the adult mammary fat pad [38]. It is
possible that our AFS lines emerged from a germ-layer
lineage that is not conducive to differentiate into epithe-
lium in response to the signals provided by the mammary
fat pad, even in the presence of MECs. In concordance
with this notion is the observation that neural stem cells
[21] are able to differentiate into mammary epithelium,
but only after cotransplantation with MECs depleted of
endogenous stem cells and after the hormonal stimulus
exerted during pregnancy. These cells are derived from
the same germ layer as the mammary gland, the ectoderm
that might account for this differentiation potential.
Alternatively, it is possible that the AFSs are not
exposed to the proper signals required for mammary
epithelial differentiation. The timing of the exposure and
the cellular environment might contribute influences that
we cannot control at present. This might explain the pre-
sence of a small number of AFS-derived cells within an
alveolar unit during pregnancy. Interestingly, transplanta-
tion under the renal capsule indicates that mammary
mesenchyme can be replaced by salivary [38] or prostatic
[39] mesenchyme to facilitate mammary epithelial mor-
phogenesis. Based on these observations, it is conceivable
that the AFS-derived mesenchyme supports mammary
epithelial morphogenesis. In contrast to cleared mam-
mary fat pads, the renal capsule is a highly vasculogenic
graft site that supports the engraftment of human
mammary tissue and other heterologous tissue compo-
nents. For this reason, it has been used in many tissue-
transplantation studies [40].
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with the observations we made in the in vitro experiments.
AFSs participate in the ductal outgrowth, persist over long
periods in association with the luminal and myoepithelial
cells, but do not become part of the ductal epithelial struc-
tures. They contribute mesenchymal components to the
glandular epithelium and are remarkably motile. Because
of this motile phenotype, it is not too surprising that AFS-
derived cells are occasionally incorporated into mammary
epithelial structures during pregnancy. The inoculated
AFSs proliferate, and their progeny can be detected in a
number of distant organs several weeks after transplanta-
tion. LacZ
+ cells were found in other epithelial tissue, such
as the lung and the mucosa of the gastrointestinal tract.
LacZ
+ cells at these sites were incorporated into the tis-
sues. Previous reports have shown that BM-MSCs and
AFS can contribute to airway-epithelium restoration
[30,31,41], and BM-MSCs migrate and participate in gas-
trointestinal tract mucosa regeneration after damage [42].
The ability of AFSs to migrate and engraft at distant sites
and to incorporate into the gastrointestinal mucosa sug-
gests that the signals of the microenvironment can influ-
ence the cell fate of AFSs.
Conclusions
The observation that undifferentiated AFSs survive in a
permissive environment and have the potential to differ-
entiate into multiple cell types makes them interesting
candidates for use as therapeutic cells and for their
application in tissue repair. Here we demonstrated that
the signals provided by the mammary microenvironment
and the communication between AFSs and mammary
epithelium favor the formation of supportive stroma for
the extending ductal epithelium, but do not cause the
epithelial differentiation of AFSs. AFSs exhibit a remark-
ably motile phenotype, and their ability to migrate from
the mammary fat pad to other organs might shed light
on mechanisms of metastasis formation.
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